25th Jun 2015 11:16
TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:
Spire Healthcare Group plc
2. Reason for the notification (please state Yes/No):
An acquisition or disposal of voting rights: YES
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached:
An event changing the breakdown of voting rights: ( )
Other (please specify): Transfer of shares to 100% owned (in identical ratios) special purpose vehicle (Rozier Investments Limited Partnership)
3. Full name of person(s) subject to the notification obligation:
REMGRO LIMITED
4. Full name of shareholder(s) (if different from 3.):
REMGRO JERSEY LIMITED
5. Date of the transaction (and date on which the threshold is crossed or reached if different): 22 June 2015
6. Date on which issuer notified: 24 June 2015
7. Threshold(s) that is/are crossed or reached:
Prior to transaction: below 3%
Subsequent to transaction: 29.9%
8. Notified details: | |||||||
A: Voting rights attached to shares viii, ix | |||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | |||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights x | |||
Direct | Direct xi | Indirect xii | Direct | Indirect | |||
ORDINARY ISIN: GB00BNLPYF73 | 0 | 0 | 119,923,335 | 29.9% | |||
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument | Expiration Date | Exercise/Conversion Period/ Date | Number of voting rights that may be acquired if the instrument is exercised/ converted. | % of voting rights |
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument | Exercise price | Expiration date | Exercise/Conversion period | Number of voting rights instrument refers to | % of voting rights | |
Nominal | Delta | |||||
Total (A+B+C)
Number of voting rights | % of voting rights |
119,923,335 | 29.9% |
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
1. Remgro Limited (Ultimate Parent): indirect holding of 29.9% of voting rights in issuer
2. Remgro Healthcare Holdings (Pty) Limited (wholly owned subsidiary of Remgro Limited): indirect holding of 29.9% of voting rights in issuer
3. Business Venture Investments No 1871 (Pty) Ltd (wholly owned subsidiary of Remgro Healthcare Holdings (Pty) Limited): indirect holding of 29.9% of voting rights in issuer
4. Remgro Jersey Limited (wholly owned subsidiary of Business Venture Investments No 1871 (Pty) Ltd): direct holding of 29.9% of voting rights in issuer
Proxy Voting:
10. Name of the proxy holder: N/A
11. Number of voting rights proxy holder will cease to hold: N/A
12. Date on which proxy holder will cease to hold voting rights: N/A
13. Additional information: See box 9 above
14. Contact name:
Anthony Dand, Interim Deputy Secretary, Spire Healthcare Group plc
15. Contact telephone number:
+ 44 (0)20 7427 9092
Related Shares:
Spire Healthcare